339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter
Publication
, Conference
Franco, LM; Sun, B; Bird, A; Zhang, H; Amalfitano, A; Chen, Y-T; Koeberl, DD
Published in: Molecular Therapy
May 2004
Duke Scholars
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2004
Volume
9
Start / End Page
S129 / S129
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Franco, L. M., Sun, B., Bird, A., Zhang, H., Amalfitano, A., Chen, Y.-T., & Koeberl, D. D. (2004). 339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter. In Molecular Therapy (Vol. 9, pp. S129–S129). Elsevier BV. https://doi.org/10.1038/mt.2004.1400
Franco, Luis M., Baodong Sun, Andrew Bird, Haoyue Zhang, Andrea Amalfitano, Y. -. T. Chen, and Dwight D. Koeberl. “339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter.” In Molecular Therapy, 9:S129–S129. Elsevier BV, 2004. https://doi.org/10.1038/mt.2004.1400.
Franco LM, Sun B, Bird A, Zhang H, Amalfitano A, Chen Y-T, et al. 339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter. In: Molecular Therapy. Elsevier BV; 2004. p. S129–S129.
Franco, Luis M., et al. “339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter.” Molecular Therapy, vol. 9, Elsevier BV, 2004, pp. S129–S129. Crossref, doi:10.1038/mt.2004.1400.
Franco LM, Sun B, Bird A, Zhang H, Amalfitano A, Chen Y-T, Koeberl DD. 339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter. Molecular Therapy. Elsevier BV; 2004. p. S129–S129.
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2004
Volume
9
Start / End Page
S129 / S129
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences